全文获取类型
收费全文 | 33995篇 |
免费 | 16068篇 |
国内免费 | 4篇 |
出版年
2024年 | 4篇 |
2023年 | 58篇 |
2022年 | 200篇 |
2021年 | 606篇 |
2020年 | 2305篇 |
2019年 | 3852篇 |
2018年 | 4013篇 |
2017年 | 4246篇 |
2016年 | 4365篇 |
2015年 | 4452篇 |
2014年 | 4168篇 |
2013年 | 4684篇 |
2012年 | 2499篇 |
2011年 | 2245篇 |
2010年 | 3530篇 |
2009年 | 2158篇 |
2008年 | 1177篇 |
2007年 | 777篇 |
2006年 | 697篇 |
2005年 | 763篇 |
2004年 | 665篇 |
2003年 | 635篇 |
2002年 | 577篇 |
2001年 | 323篇 |
2000年 | 235篇 |
1999年 | 208篇 |
1998年 | 97篇 |
1997年 | 68篇 |
1996年 | 58篇 |
1995年 | 62篇 |
1994年 | 51篇 |
1993年 | 45篇 |
1992年 | 30篇 |
1991年 | 29篇 |
1990年 | 27篇 |
1989年 | 19篇 |
1988年 | 14篇 |
1987年 | 11篇 |
1986年 | 14篇 |
1985年 | 9篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 15篇 |
1981年 | 11篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1975年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 843 毫秒
901.
Tracie Pennimpede Stefanie Wolter Lars Wittler Anne‐Karoline Ebert Wolfgang Rösch Raimund Stein Enrika Bartels Dominik Schmidt Thomas M. Boemers Eberhard Schmiedeke Per Hoffmann Susanne Moebus Bernhard G. Herrmann Markus M. Nöthen Heiko Reutter Michael Ludwig 《Birth defects research. Part A, Clinical and molecular teratology》2013,97(3):133-139
902.
903.
904.
905.
906.
907.
Eva C. Schulte Immanuel Stahl Darina Czamara Daniel C. Ellwanger Sebastian Eck Elisabeth Graf Brit Mollenhauer Alexander Zimprich Peter Lichtner Dietrich Haubenberger Walter Pirker Thomas Brücke Benjamin Bereznai Maria J. Molnar Annette Peters Christian Gieger Bertram Müller-Myhsok Claudia Trenkwalder Juliane Winkelmann 《PloS one》2013,8(11)
Approximately 20% of individuals with Parkinson’s disease (PD) report a positive family history. Yet, a large portion of causal and disease-modifying variants is still unknown. We used exome sequencing in two affected individuals from a family with late-onset familial PD followed by frequency assessment in 975 PD cases and 1014 ethnically-matched controls and linkage analysis to identify potentially causal variants. Based on the predicted penetrance and the frequencies, a variant in PLXNA4 proved to be the best candidate and PLXNA4 was screened for additional variants in 862 PD cases and 940 controls, revealing an excess of rare non-synonymous coding variants in PLXNA4 in individuals with PD. Although we cannot conclude that the variant in PLXNA4 is indeed the causative variant, these findings are interesting in the light of a surfacing role of axonal guidance mechanisms in neurodegenerative disorders but, at the same time, highlight the difficulties encountered in the study of rare variants identified by next-generation sequencing in diseases with autosomal dominant or complex patterns of inheritance. 相似文献
908.
Sara Montanari Munazza Saeed Mareike Kn?bel YoonKyeong Kim Michela Troggio Mickael Malnoy Riccardo Velasco Paolo Fontana KyungHo Won Charles-Eric Durel Laure Perchepied Robert Schaffer Claudia Wiedow Vincent Bus Lester Brewer Susan E. Gardiner Ross N. Crowhurst David Chagné 《PloS one》2013,8(10)
We have used new generation sequencing (NGS) technologies to identify single nucleotide polymorphism (SNP) markers from three European pear (Pyrus communis L.) cultivars and subsequently developed a subset of 1096 pear SNPs into high throughput markers by combining them with the set of 7692 apple SNPs on the IRSC apple Infinium® II 8K array. We then evaluated this apple and pear Infinium® II 9K SNP array for large-scale genotyping in pear across several species, using both pear and apple SNPs. The segregating populations employed for array validation included a segregating population of European pear (‘Old Home’בLouise Bon Jersey’) and four interspecific breeding families derived from Asian (P. pyrifolia Nakai and P. bretschneideri Rehd.) and European pear pedigrees. In total, we mapped 857 polymorphic pear markers to construct the first SNP-based genetic maps for pear, comprising 78% of the total pear SNPs included in the array. In addition, 1031 SNP markers derived from apple (13% of the total apple SNPs included in the array) were polymorphic and were mapped in one or more of the pear populations. These results are the first to demonstrate SNP transferability across the genera Malus and Pyrus. Our construction of high density SNP-based and gene-based genetic maps in pear represents an important step towards the identification of chromosomal regions associated with a range of horticultural characters, such as pest and disease resistance, orchard yield and fruit quality. 相似文献
909.
Claudia Palladino Verónica Briz José María Bellón Inês Bártolo Patrícia Carvalho Ricardo Camacho M. ángeles Mu?oz-Fernández Rui Bastos Rolanda Manuel José Casanovas Nuno Taveira 《PloS one》2013,8(12)
In Mozambique, the evaluation of retention in HIV care and ART programmes is limited. To assess rate and predictors of attrition (no retention in care) and HAART effectiveness in HIV-1 infected patients who pay for medication and laboratory testing in Mozambique, we conducted a multicenter survey of HIV-1-infected patients who started HAART during 2002–2006. Cox proportional hazard models were used to assess risk of attrition and of therapy failure. Overall, 142 patients from 16 healthcare centers located in the capital city Maputo were followed-up for 22.2 months (12.1–46.7). The retention rate was 75%, 48% and 37% after one, two and three years, respectively. Risk of attrition was lower in patients with higher baseline CD4 count (P = 0.022) and attending healthcare center 1 (HCC1) (P = 0.013). The proportion of individuals with CD4 count ≤200 cells/µL was 55% (78/142) at baseline and decreased to 6% (3/52) at 36 months. Among the patients with available VL, 86% (64/74) achieved undetectable VL levels. The rate of immunologic failure was 17.2% (95% CI: 12.6–22.9) per 100 person-years. Risk of failure was associated to higher baseline CD4 count (P = 0.002), likely reflecting low adherence levels, and decreased with baseline VL ≥10,000 copies/mL (P = 0.033). These results suggest that HAART can be effective in HIV-1 infected patients from Mozambique that pay for their medication and laboratory testing. Further studies are required to identify the causes for low retention rates in patients with low CD4 counts and to better understand the association between healthcare setting and attrition rate. 相似文献
910.
Aldo Scarpa Katarzyna Sikora Matteo Fassan Anna Maria Rachiglio Rocco Cappellesso Davide Antonello Eliana Amato Andrea Mafficini Matilde Lambiase Claudia Esposito Emilio Bria Francesca Simonato Maria Scardoni Giona Turri Marco Chilosi Giampaolo Tortora Ambrogio Fassina Nicola Normanno 《PloS one》2013,8(11)
Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents that are already approved for clinical use or are in clinical trials. Therefore, the number of biomarkers that will be needed to assess is expected to rapidly increase. This calls for the implementation of methods probing the mutational status of multiple genes for inoperable cases, for which limited cytological or bioptic material is available. Cytology specimens from 38 lung adenocarcinomas were subjected to the simultaneous assessment of 504 mutational hotspots of 22 lung cancer-associated genes using 10 nanograms of DNA and Ion Torrent PGM next-generation sequencing. Thirty-six cases were successfully sequenced (95%). In 24/36 cases (67%) at least one mutated gene was observed, including EGFR, KRAS, PIK3CA, BRAF, TP53, PTEN, MET, SMAD4, FGFR3, STK11, MAP2K1. EGFR and KRAS mutations, respectively found in 6/36 (16%) and 10/36 (28%) cases, were mutually exclusive. Nine samples (25%) showed concurrent alterations in different genes. The next-generation sequencing test used is superior to current standard methodologies, as it interrogates multiple genes and requires limited amounts of DNA. Its applicability to routine cytology samples might allow a significant increase in the fraction of lung cancer patients eligible for personalized therapy. 相似文献